Oleamide
Oleamide is an endogenous fatty acid amide which can be synthesized de novo in the mammalian nervous system, and has been detected in human plasma.
Product Specifications
CAS Number
[301-02-0]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/Oleamide.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : ≥ 100 mg/mL
Smiles
CCCCCCCC/C=C\CCCCCCCC(N)=O
Molecular Formula
C18H35NO
Molecular Weight
281.48
Precautions
H302, H315, H319, H335
References & Citations
[1]Mendelson WB, et al. The hypnotic actions of the fatty acid amide, oleamide. Neuropsychopharmacology. 2001 Nov;25 (5 Suppl) :S36-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal TDO2 Antibody (OTI1D1) [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MARCH7 (Membrane-Associated Ring Finger (C3HC4) 7, AXO, AXOT, DKFZp586F1122, MARCH-VII, RNF177) (MaxLight 650)
PDCD10, ID (PDCD10, CCM3, TFAR15, Programmed cell death protein 10, Cerebral cavernous malformations 3 protein, TF-1 cell apoptosis-related protein 15) (MaxLight 550)
PDCD10, ID (PDCD10, CCM3, TFAR15, Programmed cell death protein 10, Cerebral cavernous malformations 3 protein, TF-1 cell apoptosis-related protein 15) (MaxLight 550)
